2024/10/31 07:00:00 | |
---|---|
Price | |
20,725.00 JPY | |
Difference | 0.97% (200.00) |
ISIN | JP3837800006 |
Symbol | 7741 |
Exchange | Tokyo Stock Exchange |
Currency | JPY |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 43,161 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 20,720.00 JPY (500) |
Ask (Ask size) | 20,810.00 JPY (100) |
Open | 20,375.00 JPY |
High | 21,200.00 JPY |
Low | 20,120.00 JPY |
Close (prev. day) | 20,525.00 JPY |
VWAP | 20,644.9833 JPY |
Volume (pcs) | 1,681,000 |
Trading volume | 347,042,170.00 |
Number of trades | 6,088 |
Last size | 419,400 |
Related Futures | - |
Related Options | - |
2024/10/31 07:00:00 | |
---|---|
Price | |
20,725.00 JPY | |
Difference | 0.97% (200.00) |
ISIN | JP3837800006 |
Symbol | 7741 |
Exchange | Tokyo Stock Exchange |
Currency | JPY |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 43,161 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 20,720.00 JPY (500) |
Ask (Ask size) | 20,810.00 JPY (100) |
Open | 20,375.00 JPY |
High | 21,200.00 JPY |
Low | 20,120.00 JPY |
Close (prev. day) | 20,525.00 JPY |
VWAP | 20,644.9833 JPY |
Volume (pcs) | 1,681,000 |
Trading volume | 347,042,170.00 |
Number of trades | 6,088 |
Last size | 419,400 |
6m | 1Y | 3Y | |
Perf (%) | +11.32% | - | - |
Perf (abs.) | +12.50 | - | - |
Beta | 0.98 | 1.00 | 1.14 |
Volatility | - | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 20,218.00 JPY (1,037,360) |
Ø price 30 days | Ø volume 30 days (pcs.) | 20,261.33 JPY (874,593) |
Ø price 100 days | Ø volume 100 days (pcs.) | 19,590.80 JPY (1,009,379) |
Ø price 250 days | Ø volume 250 days (pcs.) | 18,519.16 JPY (997,509) |
YTD High | date | 21,645.00 JPY (2024/10/10) |
YTD Low | date | 15,870.00 JPY (2024/08/05) |
52 Weeks High | date | 21,645.00 JPY (2024/10/10) |
52 Weeks Low | date | 14,695.00 JPY (2023/11/01) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/30 | 22:02 | 122.85 EUR | 0.00 | 1 |
Tokyo Stock Exchange | 2024/10/31 | 07:00 | 20,725.00 JPY | 347.04 | 6,088 |
Stuttgart | 2024/10/31 | 08:41 | 123.90 EUR | 0.00 | 1 |
Munich | 2024/10/31 | 08:08 | 124.10 EUR | 0.00 | 1 |
Hanover | 2024/10/31 | 08:01 | 124.00 EUR | 0.00 | 1 |
Frankfurt | 2024/10/31 | 08:16 | 124.05 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/10/29 | 20:46 | 131.20 USD | 0.07 | 17 |
Duesseldorf | 2024/10/31 | 09:30 | 122.65 EUR | 0.00 | 2 |
Berlin | 2024/10/31 | 10:05 | 123.95 EUR | 0.00 | 3 |
HOYA CORP. |
- - |
Nittochi Nishishinjuku Building 20/F, 6-10-1 Nishi-Shinjuku - 160-8347 Tokyo |
Telefon: +81-3-6911-4811 |
Fax: + |
E-mail: - |
HOYA Corp. engages in the manufacture and sale of imaging products, electronics, and medical-related equipment. It operates through the following segments: Information Technology, Life Care, and Others. The Information Technology segment develops, sells and produces input and output (I/O) device related products for the information & communications sector, including imaging, modern digital information and communications technology related products. The Life Care segment produces and sells health care & medical related products. The Others segment includes the information system services and business contracts. The company was founded by Shigeru Yamanaka and Shoichi Yamanaka on November 1, 1941 and is headquartered in Tokyo, Japan. |
Eiichiro Ikeda | Chairman of Managing Board |
Ryo Hirooka | Member of Executive Committee |
Tomoko Nakagawa | Member of Executive Committee |
Hiroaki Yoshihara | Member of Supervisory Board |
Hiroshi Suzuki | Member of Supervisory Board |
Mika Nishimura | Member of Supervisory Board |
Mitsudo Urano | Member of Supervisory Board |
Shuzo Kaihori | Member of Supervisory Board |
Yasuyuki Abe | Member of Supervisory Board |
Yukako Uchinaga | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer